Article · 29 Aug 2026
Research articlePublished 2016
Cross-Sectoral Perspectives of Market Implementation of the MVA Platform for Influenza Vaccines: Regulatory, Industry and Academia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This study provides a quantitative multidisciplinary approach to identify and prioritize the main implementation challenges of the MVA platform for novel influenza vaccines using a tailor-made prioritization process. Influential key opinion leaders (KOL’s) in the field of vaccine research, development, and manufacturing were approached to participate in this study. Semi-structured interviews were performed with 32 KOL’s representing the regulatory, industry, and academia fields. The opinions were analyzed quantitatively, through various ranking methods that were integrated and adapted to fit the purpose of this study, identifying 6 implementation challenges main categories, 21 implementation challenges categories, and 39 implementation challenges underlying causes. The most significant barriers are associated with “production & speed” category whereas the least significant are associated with “regulatory” category. Perspectives among the KOL’s proved to be divergent with regard to implementation challenges for the MVA platform. Through comparing these perspectives, useful information on current and potential future implementation challenges of novel platforms in general may be expected. Providing an overview and assessment to reveal these challenges may lead to a more substantial situation for all stakeholders involved, given that such an overview allows for the recognition of various implementation challenges from a multidisciplinary perspective, making it possible to identify underlying causes that contribute to the successful implementation of the MVA platform. Remarkably, analysis of implementation challenges resulted in core challenges that resemble similarities between the three perspectives.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Bahar Ramezanpour”
- BylineArticles whose byline prints “Osterhaus A”
- BylineArticles whose byline prints “Claassen E”